Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12667-12675
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12667
Figure 4
Figure 4 Comparison of prevalence rate of cytomegalovirus infection in 4 groups, including, ulcerative colitis inactive patients with immunosuppressive drugs, ulcerative colitis inactive patients without immunosuppressive drugs, ulcerative colitis active patients with immunosuppressive drugs, and ulcerative colitis active patients without immunosuppressive drugs. CMV: Cytomegalovirus.